SCHEMBL30225664

SCHEMBL30225664

CCN(C)C(=O)OC(N)=O

nearest known ligand 0.39

Predicted protein targets (top 13)

geneUniProtsupporting neighboursconfidence
ALOX15 P16050 1/20 0.39
ACHE P22303 10/20 0.36
BCHE P06276 5/20 0.33
FAAH O00519 1/20 0.33
CHRNB2 P17787 2/20 0.32
CHRNA4 P43681 2/20 0.32
CHRNB4 P30926 1/20 0.32
CHRNA3 P32297 1/20 0.32
CHRM2 P08172 1/20 0.32
CHRM4 P08173 1/20 0.32
CHRM5 P08912 1/20 0.32
CHRM1 P11229 1/20 0.32
CHRM3 P20309 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11077833 0.82 ACHE (0.34) ALOX15ACHEBCHEFAAHCHRNB2
SCHEMBL2777834 0.78 MEN1 (0.45) ALOX15ACHEBCHE
SCHEMBL13735517 0.75
SCHEMBL12877872 0.74 TDP1 (0.44) ACHEBCHEFAAHCHRNB2CHRNA4
SCHEMBL2778900 0.74
SCHEMBL11344389 0.73 ACHE (0.33) ACHEBCHEFAAHCHRNB2CHRNA4
SCHEMBL2099259 0.72
SCHEMBL5459979 0.71
SCHEMBL293056 0.71
SCHEMBL8888937 0.70

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4121043-A1 MDM2 DEGRADERS AND USES THEREOF Kymera Therapeutics, Inc. (US) 2023-01-25 EP disclosed